4
Changes in Ownership
REGENERON PHARMACEUTICALS, INC. Filed Acc 0001968202-23-000005
EVP Commercial sold 1,100 shares at $818.80 ($900,680)
- EVP Commercial acquired 1,100 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
McCourt Marion · EVP Commercial
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-04-03 | Exercise or conversion : show line 1 in the form 10b5-1 | +1,100 | $372.46 | $409,706 | 21,903 | D |
| 2023-04-03 | Sale : show line 2 in the form 10b5-1 | −1,100 | $818.80 | $900,680 | 20,803 | D |
| Open-market sales · 1,100 sh · avg $818.80 · $900,680 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-04-03 | Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −1,100 | 4,450 | D |
Loading xslF345X04/edgardoc.xml…